Fisher Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.88M | Buy |
|
|||||
|
2025
Q1 | $9.54M | Buy |
|
|||||
|
2024
Q4 | $12.4M | Buy |
|
|||||
|
2024
Q3 | $16.5M | Buy |
|
|||||
|
2024
Q2 | $9.97M | Buy |
|
|||||
|
2024
Q1 | $8.28M | Buy |
|
|||||
|
2023
Q4 | $3.02M | Buy |
|
|||||
|
2023
Q3 | $2.29M | Sell |
|
|||||
|
2023
Q2 | $3.95M | Sell |
|
|||||
|
2023
Q1 | $4.27M | Sell |
|
|||||
|
2022
Q4 | $2.76M | Buy |
|
|||||
|
2022
Q3 | $2.41M | Buy |
|
|||||
|
2022
Q2 | $1.31M | Buy |
|
|||||
|
2022
Q1 | $1.8M | Sell |
|
|||||
|
2021
Q4 | $2.38M | Buy |
|
|||||
|
2021
Q3 | $1.9M | Buy |
|
|||||
|
2021
Q2 | $1.64M | Sell |
|
|||||
|
2021
Q1 | $1.65M | Buy |
|
|||||
|
2020
Q4 | $1.05M | Buy |
|
|||||
|
2020
Q3 | $649K | Sell |
|
|||||
|
2020
Q2 | $700K | Buy |
|
|||||
|
2020
Q1 | $882K | Buy |
|
|||||
|
2019
Q4 | $1.68M | Sell |
|
|||||
|
2019
Q3 | $5.19M | Buy |
|
|||||
|
2019
Q2 | $3.83M | Buy |
|
|||||
|
2019
Q1 | $4.34M | Sell |
|
|||||
|
2018
Q4 | $3.85M | Buy |
|
|||||
|
2018
Q3 | $5.9M | Buy |
|
|||||
|
2018
Q2 | $4.41M | Buy |
|
|||||
|
2018
Q1 | $3.35M | Sell |
|
|||||
|
2017
Q4 | $4.13M | Hold |
|
|||||
|
2017
Q3 | $4.35M | Buy |
|
|||||
|
2017
Q2 | $1.58M | Hold |
|
|||||
|
2017
Q1 | $1.17M | Buy |
|
|||||
|
2016
Q4 | $996K | Sell |
|
|||||
|
2016
Q3 | $1.9M | Buy |
|
|||||
|
2016
Q2 | $2.96M | Buy |
|
|||||
|
2016
Q1 | $3.5M | Buy |
|
|||||
|
2015
Q4 | $3.88M | Hold |
|
|||||
|
2015
Q3 | $3.37M | Buy |
|
|||||
|
2015
Q2 | $2.99M | Hold |
|
|||||
|
2015
Q1 | $3.12M | Sell |
|
|||||
|
2014
Q4 | $3.01M | Buy |
|